Jenavalve Treatment for Severe Aortic Regurgitation and Stenosis

Jenavalve Treatment for Severe Aortic Regurgitation and Stenosis

Nick Amoroso, M.D., an interventional cardiologist at MUSC Health, performed South Carolina’s first TAVR for aortic regurgitation this year as part of a clinical trial for the new valve device, known as the JenaValve trilogy heart valve.


Published

October 17, 2022

Created by

The Medical University of South Carolina

Nicholas Amoroso, MD

Nicholas Amoroso, MD

Cardiology

Dr. Nicholas Amoroso is an interventional cardiologist in Charleston, SC and is affiliated with MUSC Health of Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center.

View full profile